Sign In

Login

Password

Forgot Password ? Sign Up

Covaxin (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "Covaxin" in Czech language version.

refsWebsite
Global rank Czech rank
17nih.gov
4th place
8th place
14doi.org
2nd place
4th place
10worldcat.org
5th place
3rd place
7reuters.com
49th place
92nd place
6indianexpress.com
60th place
2,149th place
6hindustantimes.com
71st place
2,675th place
6indiatimes.com
17th place
803rd place
5livemint.com
390th place
low place
3nytimes.com
7th place
43rd place
3thehindu.com
52nd place
2,627th place
3thewire.in
1,507th place
4,179th place
2cnn.com
28th place
74th place
2theprint.in
987th place
low place
2clinicaltrials.gov
5,225th place
2,661st place
2ndtv.com
138th place
4,648th place
2bbc.com
20th place
48th place
1cowin.gov.in
low place
low place
1who.int
195th place
168th place
1thelancet.com
2,393rd place
974th place
1businesstoday.in
1,332nd place
low place
1thehindubusinessline.com
724th place
8,059th place
1financialexpress.com
798th place
low place
1ddnews.gov.in
low place
low place
1washingtonpost.com
34th place
133rd place
1harvard.edu
18th place
99th place
1thequint.com
1,282nd place
low place
1cnbctv18.com
4,062nd place
low place
1ctri.nic.in
low place
low place
1biorxiv.org
5,061st place
884th place
1sciencemag.org
857th place
315th place
1thelivemirror.com
low place
low place
1irna.ir
643rd place
low place
1web.archive.org
1st place
1st place
1cnnphilippines.com
2,993rd place
low place
1globo.com
62nd place
1,703rd place
1lexpress.mu
low place
3,172nd place
1batimes.com.ar
low place
low place

batimes.com.ar

  • Buenos Aires Times | Buenos Aires Province agrees to buy 10 million doses of Covaxin vaccine. www.batimes.com.ar [online]. [cit. 2021-11-22]. Dostupné online. 

bbc.com

  • Coronavirus: India approves vaccines from Bharat Biotech and Oxford/AstraZeneca. BBC News. 2021-01-03. Dostupné online [cit. 2021-11-22]. (anglicky) 
  • O que muda na vacinação do Brasil com decisão da Anvisa sobre Covaxin e Sputnik. BBC News Brasil. Dostupné online [cit. 2021-11-22]. (portugalsky) 

biorxiv.org

  • YADAV, Pragya D.; SAPKAL, Gajanan N.; ELLA, Raches. Neutralization against B.1.351 and B.1.617.2 with sera of COVID-19 recovered cases and vaccinees of BBV152. [s.l.]: [s.n.] Dostupné online. DOI 10.1101/2021.06.05.447177v1. S. 2021.06.05.447177. (anglicky) Type: article. 

businesstoday.in

  • Coronavirus vaccine update: Bharat Biotech's Covaxin launch likely in Q2 of 2021, no word on pricing yet. Business Today [online]. [cit. 2021-11-22]. Dostupné online. (anglicky) 

clinicaltrials.gov

  • BHARAT BIOTECH INTERNATIONAL LIMITED. An Event-Driven, Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate Efficacy, Safety, Immunogenicity, Lot-to-Lot Consistency of BBV152, a Whole-Virion Inactivated SARS-CoV-2 Vaccine in Adults≥18 Yrs of Age. [s.l.]: [s.n.] Dostupné online. Submitted: November 9, 2020. 
  • BHARAT BIOTECH INTERNATIONAL LIMITED. A Phase II/III, Open Label, Multicenter Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Whole-Virion Inactivated SARS-CoV-2 Vaccine (COVAXIN®) in Healthy Volunteers Ages ≤18 to ≥ 2 Years.. [s.l.]: [s.n.] Dostupné online. Submitted: May 18, 2021. 

cnbctv18.com

  • Bharat Biotech plans Covaxin Phase 4 trials, says will meet 'every scientific standard'. cnbctv18.com [online]. 2021-06-10 [cit. 2021-11-22]. Dostupné online. (anglicky) 

cnn.com

  • CNN, Manveena Suri and Julia Hollingsworth. India's homegrown Covid-19 vaccine has 78% efficacy against symptomatic infections, developer says. CNN [online]. [cit. 2021-11-22]. Dostupné online. 
  • Esha Mitra and Julia Hollingsworth. More than a dozen slum residents in an Indian city say they didn't know they were part of a clinical vaccine trial [online]. [cit. 2021-05-18]. Dostupné online. 

cnnphilippines.com

  • Covaxin, Janssen approved for emergency use in PH. cnn [online]. [cit. 2021-11-22]. Dostupné v archivu pořízeném z originálu dne 2021-04-20. (anglicky) 

cowin.gov.in

dashboard.cowin.gov.in

  • Cowin statistics [online]. Ministry of health and family welfare India, 23 October 2021. Dostupné online. 

ctri.nic.in

ddnews.gov.in

  • Human clinical trials of potential Covid-19 vaccine 'Covaxin' started at AIIMS. DD News. Prasar Bharati, Ministry of I & B, Government of India, 25 July 2020. Dostupné online. 

doi.org

dx.doi.org

  • KRAUSE, Philip; FLEMING, Thomas R.; LONGINI, Ira. COVID-19 vaccine trials should seek worthwhile efficacy. Lancet (London, England). 2020-09-12, roč. 396, čís. 10253, s. 741–743. PMID 32861315 PMCID: PMC7832749. Dostupné online [cit. 2021-11-22]. ISSN 1474-547X. DOI 10.1016/S0140-6736(20)31821-3. PMID 32861315. 
  • KHOURY, David S.; CROMER, Deborah; REYNALDI, Arnold. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nature Medicine. 2021-07, roč. 27, čís. 7, s. 1205–1211. PMID 34002089. Dostupné online [cit. 2021-11-22]. ISSN 1546-170X. DOI 10.1038/s41591-021-01377-8. PMID 34002089. 
  • ELLA, Raches; REDDY, Siddarth; BLACKWELDER, William; POTDAR, Varsha; YADAV, Pragya; SARANGI, Vamshi; AILENI, Vinay K. Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial. The Lancet. November 2021, s. S0140673621020006. Dostupné online. DOI 10.1016/S0140-6736(21)02000-6. 
  • ELLA, Raches; REDDY, Siddarth; BLACKWELDER, William. Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial. Lancet (London, England). 2021-11-11, s. S0140–6736(21)02000–6. PMID 34774196 PMCID: PMC8584828. Dostupné online [cit. 2021-11-22]. ISSN 1474-547X. DOI 10.1016/S0140-6736(21)02000-6. PMID 34774196. 
  • HOEKSEMA, F.; KARPILOW, J.; LUITJENS, A. Enhancing viral vaccine production using engineered knockout vero cell lines - A second look. Vaccine. 2018-04-12, roč. 36, čís. 16, s. 2093–2103. PMID 29555218 PMCID: PMC5890396. Dostupné online [cit. 2021-11-22]. ISSN 1873-2518. DOI 10.1016/j.vaccine.2018.03.010. PMID 29555218. 
  • Ella R, Vadrevu KM, Jogdand H, Prasad S, Reddy S, Sarangi V, Ganneru B, Sapkal G, Yadav P, Abraham P, Panda S, Gupta N, Reddy P, Verma S, Kumar Rai S, Singh C, Redkar SV, Gillurkar CS, Kushwaha JS, Mohapatra S, Rao V, Guleria R, Ella K, Bhargava B. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial. The Lancet. Infectious Diseases. May 2021, s. 637–646. DOI 10.1016/S1473-3099(20)30942-7. PMID 33485468. 
  • Ella R, Reddy S, Jogdand H, Sarangi V, Ganneru B, Prasad S, Das D, Raju D, Praturi U, Sapkal G, Yadav P, Reddy P, Verma S, Singh C, Redkar SV, Gillurkar CS, Kushwaha JS, Mohapatra S, Bhate A, Rai S, Panda S, Abraham P, Gupta N, Ella K, Bhargava B, Vadrevu KM. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial. The Lancet. Infectious Diseases. March 2021, s. 950–961. DOI 10.1016/S1473-3099(21)00070-0. PMID 33705727. 
  • Ganneru B, Jogdand H, Daram VK, Das D, Molugu NR, Prasad SD, Kannappa SV, Ella KM, Ravikrishnan R, Awasthi A, Jose J, Rao P, Kumar D, Ella R, Abraham P, Yadav PD, Sapkal GN, Shete-Aich A, Desphande G, Mohandas S, Basu A, Gupta N, Vadrevu KM. Th1 skewed immune response of whole virion inactivated SARS CoV 2 vaccine and its safety evaluation. iScience. April 2021, s. 102298. DOI 10.1016/j.isci.2021.102298. PMID 33723528. Bibcode 2021iSci...24j2298G. 
  • Bmj IC. India: Doctors call for investigation into allegations of ethical abuse in covid-19 vaccine trial. BMJ. January 2021, s. n131. DOI 10.1136/bmj.n131. PMID 33446480. 
  • Sapkal GN, Yadav PD, Ella R, Deshpande GR, Sahay RR, Gupta N, Vadrevu KM, Abraham P, Panda S, Bhargava B. Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2. Journal of Travel Medicine. June 2021. DOI 10.1093/jtm/taab051. PMID 33772577. 
  • Yadav PD, Sapkal GN, Abraham P, Ella R, Deshpande G, Patil DY, Nyayanit DA, Gupta N, Sahay RR, Shete AM, Panda S, Bhargava B, Mohan VK. Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. Clinical Infectious Diseases. May 2021. DOI 10.1093/cid/ciab411. PMID 33961693. 
  • Sapkal G, Yadav PD, Ella R, Abraham P, Patil DY, Gupta N, Panda S, Mohan VK, Bhargava B. Neutralization of B.1.1.28 P2 variant with sera of natural SARS-CoV-2 infection and recipients of inactivated COVID-19 vaccine Covaxin. Journal of Travel Medicine. May 2021. DOI 10.1093/jtm/taab077. PMID 34002240. 
  • YADAV, Pragya D.; SAPKAL, Gajanan N.; ELLA, Raches. Neutralization against B.1.351 and B.1.617.2 with sera of COVID-19 recovered cases and vaccinees of BBV152. [s.l.]: [s.n.] Dostupné online. DOI 10.1101/2021.06.05.447177v1. S. 2021.06.05.447177. (anglicky) Type: article. 
  • Thiagarajan K. What do we know about India's Covaxin vaccine?. BMJ. April 2021, s. n997. DOI 10.1136/bmj.n997. PMID 33879478. 

financialexpress.com

  • BIBCOL to manufacture 2 crore doses of Covaxin every month in UP [online]. 2021-05-14 [cit. 2021-11-22]. Dostupné online. (anglicky) 

globo.com

g1.globo.com

  • Anvisa aprova, com restrições, importação excepcional de doses da Covaxin e Sputnik V. G1 [online]. [cit. 2021-11-22]. Dostupné online. (portugalsky) 

harvard.edu

adsabs.harvard.edu

  • Ganneru B, Jogdand H, Daram VK, Das D, Molugu NR, Prasad SD, Kannappa SV, Ella KM, Ravikrishnan R, Awasthi A, Jose J, Rao P, Kumar D, Ella R, Abraham P, Yadav PD, Sapkal GN, Shete-Aich A, Desphande G, Mohandas S, Basu A, Gupta N, Vadrevu KM. Th1 skewed immune response of whole virion inactivated SARS CoV 2 vaccine and its safety evaluation. iScience. April 2021, s. 102298. DOI 10.1016/j.isci.2021.102298. PMID 33723528. Bibcode 2021iSci...24j2298G. 

hindustantimes.com

  • Bose J. Bharat Biotech says completed final analysis for Covaxin, claims 77.8% efficacy. Hindustan Times. 3 July 2021. Dostupné online [cit. 3 July 2021]. (anglicky) 
  • Bhaduri A. Covaxin trials in children between 2 and 18 years to begin in 10-12 days, says Niti Aayog member. Hindustan Times. 2021-05-18. Dostupné online. (anglicky) 
  • Kumar R. Covaxin trials on children begin at AIIMS-Patna. Hindustan Times. 2021-06-01. Dostupné online. (anglicky) 
  • Sarkar S. Covaxin effective in neutralising Delta, Beta variants of Covid-19: Study. Hindustan Times. 2021-06-09. Dostupné online. (anglicky) 
  • Ghosh N. Bharat Biotech seeks emergency use authorization for Covid-19 vaccine. Hindustan Times. 7 December 2020. Dostupné online. 
  • Manral K. Zimbabwe approves Covaxin, first in Africa to okay India-made Covid-19 vaccine. Hindustan Times. 4 March 2021. Dostupné online [cit. 6 March 2021]. 

indianexpress.com

  • Bharat Biotech exploring global tie-ups for Covaxin manufacturing [online]. 2020-09-24 [cit. 2021-11-22]. Dostupné online. (anglicky) 
  • Delhi: 30-year-old is first to get dose of trial drug Covaxin [online]. 2020-07-25 [cit. 2021-11-22]. Dostupné online. (anglicky) 
  • Bharat Biotech begins Covaxin Phase III trials [online]. 2020-11-18 [cit. 2021-11-22]. Dostupné online. (anglicky) 
  • Mascarenhas A. Covaxin neutralises double mutant strain of SARS-CoV-2: ICMR study. The Indian Express. 21 April 2021. Dostupné online. 
  • India’s Covaxin effectively neutralises Delta variant of Covid: US’ National Institute of Health [online]. 2021-06-30 [cit. 2021-11-22]. Dostupné online. (anglicky) 
  • Expert panel recommends granting approval for restricted emergency use of Bharat Biotech’s Covaxin [online]. 2021-01-02 [cit. 2021-11-22]. Dostupné online. (anglicky) 

indiatimes.com

timesofindia.indiatimes.com

  • MAY 7, TNN /; 2021; IST, 12:13. Bhubaneswar: ‘Expedite building of Biotech Park near city’, says CS Suresh Chandra Mohapatra | Bhubaneswar News - Times of India. The Times of India [online]. [cit. 2021-11-22]. Dostupné online. (anglicky) 
  • JUN 3, Swati Bharadwaj / TNN /; 2021; IST, 19:51. Covaxin vaccine: After US market, Bharat Biotech ties up with Ocugen for Covaxin sale in Canada | India News - Times of India. The Times of India [online]. [cit. 2021-11-22]. Dostupné online. (anglicky) 
  • Bharadwaj S. Covid-19 chokes competition in Telangana: Vax makers BB, IIL join hands. The Times of India. 29 April 2021. Dostupné online. (anglicky) 
  • Bharadwaj S. Covid-19: Bharat Biotech ramps up Covaxin capacity to 700 million doses per annum [online]. Times of India, 20 April 2021. Dostupné online. 

economictimes.indiatimes.com

  • Bharat Biotech, Ocugen to co-develop Covaxin for US market. The Economic Times. Dostupné online [cit. 2021-11-22]. 

health.economictimes.indiatimes.com

  • WWW.ETHEALTHWORLD.COM. India provides 1,00,000 doses of Covaxin to Paraguay - ET HealthWorld. ETHealthworld.com [online]. [cit. 2021-11-22]. Dostupné online. (anglicky) 

irna.ir

en.irna.ir

  • 3080. Iran issues permit for emergency use for three other COVID-19 vaccines: Official. IRNA English [online]. 2021-02-17 [cit. 2021-11-22]. Dostupné online. (anglicky) 

lexpress.mu

  • RÉDACTION, La. Dr Jagutpal: «Une cargaison de 200 000 vaccins Covaxin débarque demain». lexpress.mu [online]. 2021-03-18 [cit. 2021-11-22]. Dostupné online. (francouzsky) 

livemint.com

  • WRITER, Staff. Odisha sets June 2022 deadline to begin Covaxin production at Andharua. mint [online]. 2021-05-07 [cit. 2021-11-22]. Dostupné online. (anglicky) 
  • Bharat Biotech inks pact with Precisa Med to supply Covaxin to Brazil. mint [online]. 2021-01-12 [cit. 2021-11-22]. Dostupné online. (anglicky) 
  • ICMR teams up with Bharat Biotech to develop Covid-19 vaccine. mint [online]. 2020-05-09 [cit. 2021-11-22]. Dostupné online. (anglicky) 
  • Sen M. List of states that have started phase 3 trials of India's first Covid vaccine. mint. 2 December 2020. Dostupné online. 
  • Jaswal M. Covaxin: AIIMS Delhi to start trials on children from tomorrow, says report. mint. 2021-06-06. Dostupné online. (anglicky) 

ndtv.com

  • 70%-80% Drop In Participation For Phase 3 Trials Of Covaxin: Official. NDTV.com [online]. [cit. 2021-11-22]. Dostupné online. 
  • Som V. Brazil Says "No" To Covaxin, Bharat Biotech Explains. NDTV. 31 March 2021. Dostupné online [cit. 18 April 2021]. 

nih.gov

ncbi.nlm.nih.gov

  • KRAUSE, Philip; FLEMING, Thomas R.; LONGINI, Ira. COVID-19 vaccine trials should seek worthwhile efficacy. Lancet (London, England). 2020-09-12, roč. 396, čís. 10253, s. 741–743. PMID 32861315 PMCID: PMC7832749. Dostupné online [cit. 2021-11-22]. ISSN 1474-547X. DOI 10.1016/S0140-6736(20)31821-3. PMID 32861315. 
  • KHOURY, David S.; CROMER, Deborah; REYNALDI, Arnold. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nature Medicine. 2021-07, roč. 27, čís. 7, s. 1205–1211. PMID 34002089. Dostupné online [cit. 2021-11-22]. ISSN 1546-170X. DOI 10.1038/s41591-021-01377-8. PMID 34002089. 
  • ELLA, Raches; REDDY, Siddarth; BLACKWELDER, William. Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial. Lancet (London, England). 2021-11-11, s. S0140–6736(21)02000–6. PMID 34774196 PMCID: PMC8584828. Dostupné online [cit. 2021-11-22]. ISSN 1474-547X. DOI 10.1016/S0140-6736(21)02000-6. PMID 34774196. 
  • HOEKSEMA, F.; KARPILOW, J.; LUITJENS, A. Enhancing viral vaccine production using engineered knockout vero cell lines - A second look. Vaccine. 2018-04-12, roč. 36, čís. 16, s. 2093–2103. PMID 29555218 PMCID: PMC5890396. Dostupné online [cit. 2021-11-22]. ISSN 1873-2518. DOI 10.1016/j.vaccine.2018.03.010. PMID 29555218. 
  • Ella R, Vadrevu KM, Jogdand H, Prasad S, Reddy S, Sarangi V, Ganneru B, Sapkal G, Yadav P, Abraham P, Panda S, Gupta N, Reddy P, Verma S, Kumar Rai S, Singh C, Redkar SV, Gillurkar CS, Kushwaha JS, Mohapatra S, Rao V, Guleria R, Ella K, Bhargava B. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial. The Lancet. Infectious Diseases. May 2021, s. 637–646. DOI 10.1016/S1473-3099(20)30942-7. PMID 33485468. 
  • Ella R, Reddy S, Jogdand H, Sarangi V, Ganneru B, Prasad S, Das D, Raju D, Praturi U, Sapkal G, Yadav P, Reddy P, Verma S, Singh C, Redkar SV, Gillurkar CS, Kushwaha JS, Mohapatra S, Bhate A, Rai S, Panda S, Abraham P, Gupta N, Ella K, Bhargava B, Vadrevu KM. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial. The Lancet. Infectious Diseases. March 2021, s. 950–961. DOI 10.1016/S1473-3099(21)00070-0. PMID 33705727. 
  • Ganneru B, Jogdand H, Daram VK, Das D, Molugu NR, Prasad SD, Kannappa SV, Ella KM, Ravikrishnan R, Awasthi A, Jose J, Rao P, Kumar D, Ella R, Abraham P, Yadav PD, Sapkal GN, Shete-Aich A, Desphande G, Mohandas S, Basu A, Gupta N, Vadrevu KM. Th1 skewed immune response of whole virion inactivated SARS CoV 2 vaccine and its safety evaluation. iScience. April 2021, s. 102298. DOI 10.1016/j.isci.2021.102298. PMID 33723528. Bibcode 2021iSci...24j2298G. 
  • Bmj IC. India: Doctors call for investigation into allegations of ethical abuse in covid-19 vaccine trial. BMJ. January 2021, s. n131. DOI 10.1136/bmj.n131. PMID 33446480. 
  • Sapkal GN, Yadav PD, Ella R, Deshpande GR, Sahay RR, Gupta N, Vadrevu KM, Abraham P, Panda S, Bhargava B. Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2. Journal of Travel Medicine. June 2021. DOI 10.1093/jtm/taab051. PMID 33772577. 
  • Yadav PD, Sapkal GN, Abraham P, Ella R, Deshpande G, Patil DY, Nyayanit DA, Gupta N, Sahay RR, Shete AM, Panda S, Bhargava B, Mohan VK. Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. Clinical Infectious Diseases. May 2021. DOI 10.1093/cid/ciab411. PMID 33961693. 
  • Sapkal G, Yadav PD, Ella R, Abraham P, Patil DY, Gupta N, Panda S, Mohan VK, Bhargava B. Neutralization of B.1.1.28 P2 variant with sera of natural SARS-CoV-2 infection and recipients of inactivated COVID-19 vaccine Covaxin. Journal of Travel Medicine. May 2021. DOI 10.1093/jtm/taab077. PMID 34002240. 
  • Thiagarajan K. What do we know about India's Covaxin vaccine?. BMJ. April 2021, s. n997. DOI 10.1136/bmj.n997. PMID 33879478. 

pubmed.ncbi.nlm.nih.gov

nih.gov

  • Adjuvant developed with NIH funding enhances efficacy of India’s COVID-19 vaccine. National Institutes of Health (NIH) [online]. 2021-06-29 [cit. 2021-11-22]. Dostupné online. (anglicky) 

nytimes.com

  • CORUM, Jonathan; ZIMMER, Carl. How Bharat Biotech’s Vaccine Works. The New York Times. 2021-01-04. Dostupné online [cit. 2021-11-22]. ISSN 0362-4331. (anglicky) 
  • India's First COVID-19 Vaccine Candidate Approved for Human Trials. The New York Times. 29 June 2020. Dostupné online. 
  • CORUM, Jonathan; ZIMMER, Carl. Inside the B.1.1.7 Coronavirus Variant. The New York Times. 2021-01-18. Dostupné online [cit. 2021-11-22]. ISSN 0362-4331. (anglicky) 

reuters.com

  • MITRA, Anuron Kumar; SINGH, Shivani. Indian home-grown COVID-19 shot wins WHO emergency use approval. Reuters. 2021-11-03. Dostupné online [cit. 2021-11-22]. (anglicky) 
  • Ocugen to co-develop Bharat Biotech's COVID-19 vaccine candidate for U.S.. Reuters. 2020-12-22. Dostupné online [cit. 2021-11-22]. (anglicky) 
  • Sharma G. Nepal becomes third country to give emergency nod to Indian vaccine COVAXIN. Reuters. 19 March 2021. Dostupné online [cit. 2021-03-19]. 
  • Mexico authorizes emergency use of Indian COVID-19 vaccine. Reuters. 2021-04-07. Dostupné online [cit. 2021-11-22]. (anglicky) 
  • Mcgeever J, Paraguassu L. Brazil's Anvisa approves Russian Sputnik V vaccine, with conditions. Reuters. 4 June 2021. Dostupné online [cit. 5 June 2021]. 
  • REUTERS. Brazil health regulator cancels clinical study for Bharat Biotech vaccine. Reuters. 2021-07-26. Dostupné online [cit. 2021-11-22]. (anglicky) 
  • REUTERS. Brazil suspends import permit for Bharat Biotech's COVID-19 vaccine. Reuters. 2021-07-27. Dostupné online [cit. 2021-11-22]. (anglicky) 

sciencemag.org

  • Pulla P. Scientists criticize 'rushed' approval of Indian COVID-19 vaccine without efficacy data [online]. 2021-01-05 [cit. 2021-05-18]. Dostupné online. (anglicky) 

thehindu.com

  • Coronavirus | Covaxin Phase III trial from November. The Hindu. 2020-10-23. Dostupné online [cit. 2021-11-22]. ISSN 0971-751X. (anglicky) 
  • Coronavirus | After SII, Bharat Biotech seeks DCGI approval for Covaxin. The Hindu. 2020-12-07. Dostupné online [cit. 2021-11-22]. ISSN 0971-751X. (anglicky) 
  • REUTERS. Brazil to suspend vaccine deal with India as graft allegations probed. The Hindu. 2021-06-30. Dostupné online [cit. 2021-11-22]. ISSN 0971-751X. (anglicky) 

thehindubusinessline.com

  • BUREAU, Our. Maharashtra allows Haffkine Bio-Pharma to manufacture Covid vaccines. @businessline [online]. [cit. 2021-11-22]. Dostupné online. (anglicky) 

thelancet.com

  • ELLA, Raches; REDDY, Siddarth; BLACKWELDER, William; POTDAR, Varsha; YADAV, Pragya; SARANGI, Vamshi; AILENI, Vinay K. Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial. The Lancet. November 2021, s. S0140673621020006. Dostupné online. DOI 10.1016/S0140-6736(21)02000-6. 

thelivemirror.com

  • COVID-19: Covaxin Vaccine Approved For Children Between 2 to 18 [online]. 2021-10-12 [cit. 2021-11-22]. Dostupné online. (anglicky) 

theprint.in

  • Chakrabarti A. India to develop 'fully indigenous' Covid vaccine as ICMR partners with Bharat Biotech. ThePrint. 10 May 2020. Dostupné online. 
  • GHOSH, Abantika. Bharat Biotech’s Covaxin given conditional nod based on incomplete Phase 3 trial results data [online]. 2021-01-03 [cit. 2021-11-22]. Dostupné online. (anglicky) 

thequint.com

  • Pulla P. Explained: Is the Data From Covaxin Trial's Bhopal Site Tainted? [online]. 2021-02-09 [cit. 2021-05-18]. Dostupné online. (anglicky) 

thewire.in

science.thewire.in

  • Bhuyan A. How Covaxin Trial Participants in Bhopal Were Misled [online]. 2021-01-14 [cit. 2021-05-18]. Dostupné online. (anglicky) 
  • Mukunth V. Covaxin Trial's Info Sheet Skips Mention of Two Rare but Known Risks [online]. 2021-01-29 [cit. 2021-05-18]. Dostupné online. (anglicky) 
  • MUKUNTH, Vasudevan. Despite Mounting Disputes, Govt Presses Ahead With Vaccine Roll Out [online]. 2021-01-12 [cit. 2021-11-22]. Dostupné online. (anglicky) 

washingtonpost.com

web.archive.org

  • Covaxin, Janssen approved for emergency use in PH. cnn [online]. [cit. 2021-11-22]. Dostupné v archivu pořízeném z originálu dne 2021-04-20. (anglicky) 

who.int

  • WHO issues emergency use listing for eighth COVID-19 vaccine. www.who.int [online]. [cit. 2021-11-22]. Dostupné online. (anglicky) 

worldcat.org